MAIA Biotechnology (MAIA) Shares Outstanding (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Shares Outstanding (Entity) of $45.2 million for Q1 2026, up 52.81% year-over-year from $29.6 million in Q1 2025, and up 40.78% quarter-over-quarter from $32.1 million in Q4 2025.
MAIA Biotechnology (MAIA) Shares Outstanding (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Shares Outstanding (Entity) for 6 consecutive years, with $45.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 52.81% year-over-year to $45.2 million; the TTM figure through Mar 2026 stood at $45.2 million (up 52.81% YoY), while the FY2025 annual figure was $32.1 million, up 22.77% from the prior year.
- Shares Outstanding (Entity) grew to $45.2 million in Q1 2026 per MAIA's latest filing, from $32.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $45.2 million in Q1 2026 and bottomed at $7.9 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $21.0 million across 5 years, with a median of $20.6 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 113.82% — and 2023, when it increased 21.04%.
- MAIA Biotechnology's Shares Outstanding (Entity) stood at $11.0 million in 2022, then climbed by 21.04% to $13.3 million in 2023, then soared by 97.25% to $26.2 million in 2024, then increased by 22.77% to $32.1 million in 2025, then soared by 40.78% to $45.2 million in 2026.
- Business Quant data shows MAIA's Shares Outstanding (Entity) at $45.2 million in Q1 2026, $32.1 million in Q4 2025, and $34.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | 60.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.79 Mn |
| Mar 31, 2026 | 45.21 Mn |
| Dec 31, 2025 | 32.11 Mn |
| Sep 30, 2025 | 33.20 Mn |
| Jun 30, 2025 | 30.30 Mn |
| Mar 31, 2025 | 27.70 Mn |
| Dec 31, 2024 | 22.20 Mn |
| Sep 30, 2024 | 23.89 Mn |
| Jun 30, 2024 | 22.20 Mn |
| Mar 31, 2024 | 17.60 Mn |
| Dec 31, 2023 | 13.26 Mn |
| Sep 30, 2023 | 13.68 Mn |
| Jun 30, 2023 | 12.89 Mn |
| Mar 31, 2023 | 10.98 Mn |
| Dec 31, 2022 | 9.28 Mn |
| Sep 30, 2022 | 10.17 Mn |
| Jun 30, 2022 | 8.20 Mn |
| Mar 31, 2022 | 7.75 Mn |
| Dec 31, 2021 | 5.28 Mn |
| Sep 30, 2021 | 5.12 Mn |